This article was originally distributed via PRWeb. PRWeb, WorldNow and this Site make no warranties or representations in connection therewith.
MarketReportsOnline.com adds "Alzheimers Disease Patients & Market Worldwide, Future Scenario (2010 2015) & Drugs Analysis" report to its research store.
Dallas, Texas (PRWEB) July 02, 2014
Alzheimers is a complex disease and there is no single magic bullet available in the market to prevent or cure it. Though many marketed drugs have been approved for Alzheimers disease, it still remains a significant area of unmet medical need. Clinical success has proven elusive; however, numerous companies are developing novel treatments. Currently theres no cure for Alzheimers and its still waiting for its key product. In addition, all current marketed products are going to be generic in the next five years.
In 2010, there were more than 30 Million people suffering with Alzheimers disease but it is anticipated that by 2015 over 35 Million people worldwide will be suffering from this disease. Much of this increase will be due to increase in number of people with Alzheimers in low and middle income countries. Since the risk of getting the disease increases with age, the number of patients with the illness to be found in any community will depend on the proportion of older people in the group. Traditionally, the developed countries have large proportions of elderly people, and so they have many cases of Alzheimers disease in the community at one time. However, developing countries are also undergoing a demographic transition so that more and more persons are surviving to an old age.
Purchase a copy of this report @ http://www.marketreportsonline.com/contacts/purchase.php?name=344696.
Global Alzheimers disease has increased manifold and expected to cross US$ 19 Billion by 2015. North America controls more than 50% of the total Alzheimers drug market share in 2010. Over the past years, the Alzheimers disease market has been flagged with several drugs into the market. Till last year Aricept was the world best selling drug which lost patent protection in November 2010, a milestone that will be followed by a rapid loss in sales. But there are other drugs which has the potential to become blockbuster drug by 2010. Namenda, Exelon has shown alluring growth in the market and become blockbusters in 2010. Ebixa a drug of Memantine group is expected to have a Billion dollar market by 2014. Given the alarming worldwide growth in Alzheimers patients, and especially if companies are able to address major unmet needs, the outlook for the Alzheimers disease market is excellent.
This report titled Alzheimers Disease Patients & Market Worldwide, Future Scenario (2010 2015) & Drugs Analysis studies the Alzheimers Disease patients prevalence worldwide and region wise. The report provides data on the Alzheimers Disease market Worldwide, North America, Europe and Rest of the world.
Complete report available @ http://www.marketreportsonline.com/344696.html.
Key Company Profiles
This section provides business overview and key financial information of the companies listed below: Forest Laboratories, Eisai, H. Lundbeck A/S, Novartis, Merz GmbH & Co. KGaA, Johnson & Johnson, UCB
Alzheimers drugs such as Exelon, Aricept, Namenda, Razadyne, Axura, Ebixa, Nootropil, Prometax, Memac, Eranz market past, present and future scenario has been analyzed in this report.
Major points from Table of contents (http://www.marketreportsonline.com/344696-toc.html) are listed below:
1. Executive Summary
2. Worldwide Prevalence of Alzheimers Patients
3. Regional Estimates for Alzheimers Patients
4. Worldwide Alzheimers Disease Market
5. Worldwide Alzheimers Drug Market Share 2008 2009
6. Worldwide Top 10 Alzheimers Drug Brands Market Performance
7. Alzheimers Disease Deals, 2005 2009
8. Key Drivers of Growth in Global Alzheimers Disease Drug Market
9. Key Challenges in the Global Alzheimers Disease Drug Market
10. Key Players in the Alzheimers Drug Market
List of Tables
Explore more reports on Pharmaceuticals Market @ http://www.marketreportsonline.com/cat/pharmaceuticals-market-research.html.
MarketReportsOnline.com is an online database of regional industry research reports, company profiles and SWOT analysis studies for multiple industries, organizations and market segments. Our sales and research experts offer 24 X 7 support to our customers through phone and email communication. Not limited to the pharmaceuticals industry, MarketReportsOnline.com offers research studies on agriculture, travel & hospitality, consumer goods, semiconductor and electronics, retail, environment, food and beverages, it & telecommunication, agriculture, chemicals, healthcare, chemicals, advanced materials, energy and power, medical devices and much more.
For the original version on PRWeb visit: http://www.prweb.com/releases/global-alzheimer-disease/patients-market-analysis/prweb11992520.htm
Information contained on this page is provided by an independent third-party content provider. WorldNow and this Station make no warranties or representations in connection therewith. If you have any questions or comments about this page please contact email@example.com.